Avanir Pharmaceuticals Inc (NASDAQ:AVNR) Investor Alert: Lawsuit Against Takeover Filed

San Diego, CA -- (ReleaseWire) -- 12/08/2014 -- An investor, who currently holds shares of Avanir Pharmaceuticals Inc (NASDAQ:AVNR filed a lawsuit in effort to halt the proposed takeover of Avanir Pharmaceuticals Inc by Otsuka Pharmaceutical Co for $17.00 per share.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.